These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11760919)

  • 1. Vancomycin utilization at a teaching hospital in Hong Kong.
    You JH; Lyon DJ; Lee BS; Kwan SM; Tang HY
    Am J Health Syst Pharm; 2001 Nov; 58(22):2167-9. PubMed ID: 11760919
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of guidelines on vancomycin use at a Hong Kong teaching hospital.
    Lee VW; Lyon DJ; Fung KS; Leung TP; Ng JK; You JH
    Am J Health Syst Pharm; 2003 May; 60(9):949-50. PubMed ID: 12756948
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of antimicrobial stewardship program on vancomycin use in a pediatric teaching hospital.
    Di Pentima MC; Chan S
    Pediatr Infect Dis J; 2010 Aug; 29(8):707-11. PubMed ID: 20182398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health economics assessment study of teicoplanin versus vancomycin in Gram-positive infections.
    Portolés A; Palau E; Puerro M; Vargas E; Picazo JJ
    Rev Esp Quimioter; 2006 Mar; 19(1):65-75. PubMed ID: 16688294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin use and monitoring in pediatric patients in a community hospital.
    Kahyaoglu O; Akpinar M; Nolan B; Inoue S; Zureikat G; Kumar A
    Infect Control Hosp Epidemiol; 1998 May; 19(5):299, 301. PubMed ID: 9613688
    [No Abstract]   [Full Text] [Related]  

  • 6. Vancomycin vs teicoplanin in the treatment of Gram-positive infections: a pharmacoeconomic analysis in a Turkish University Hospital.
    Sancar AA; Yegenoglu S; de Vries R; Postma MJ; Simsek N; Pechlivanoglou P; Unal S
    Pharm World Sci; 2008 Dec; 30(6):916-23. PubMed ID: 18803030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin Use: Room for Improvement Among Hospitalized Children.
    Gillon J; Xu M; Slaughter J; Di Pentima MC
    J Pharm Pract; 2017 Jun; 30(3):296-299. PubMed ID: 27044642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug resistance in fecal enterococci in Hong Kong.
    Boost M; Lai L; O'Donoghue M
    J Infect Chemother; 2004 Dec; 10(6):326-30. PubMed ID: 15614455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inpatient treatment patterns, outcomes, and costs of skin and skin structure infections because of Staphylococcus aureus.
    Menzin J; Marton JP; Meyers JL; Carson RT; Rothermel CD; Friedman M
    Am J Infect Control; 2010 Feb; 38(1):44-9. PubMed ID: 19762120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-emptive intrathecal vancomycin therapy reduces external ventricular drain infection: a single centre retrospective case-control study.
    Fu RZ; Anwar DR; Laban JT; Maratos EC; Minhas PS; Martin AJ
    Br J Neurosurg; 2017 Feb; 31(1):16-20. PubMed ID: 27623701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology, appropriateness, and cost of vancomycin use.
    Jarvis WR
    Clin Infect Dis; 1998 May; 26(5):1200-3. PubMed ID: 9597253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreasing vancomycin utilization in a neonatal intensive care unit.
    Holzmann-Pazgal G; Khan AM; Northrup TF; Domonoske C; Eichenwald EC
    Am J Infect Control; 2015 Nov; 43(11):1255-7. PubMed ID: 26277573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Observations on vancomycin use in U.S. hospitals.
    Paladino JA; Sunderlin JL; Adelman MH; Singer ME; Schentag JJ
    Am J Health Syst Pharm; 2007 Aug; 64(15):1633-41. PubMed ID: 17646567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health economic evaluation of patients treated for nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus: secondary analysis of a multicenter randomized clinical trial of vancomycin and linezolid.
    Niederman MS; Chastre J; Solem CT; Wan Y; Gao X; Myers DE; Haider S; Li JZ; Stephens JM
    Clin Ther; 2014 Sep; 36(9):1233-1243.e1. PubMed ID: 25066668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct medical costs associated with using vancomycin in methicillin-resistant Staphylococcus aureus infections: an economic model.
    Shah NP; Reddy P; Paladino JA; McKinnon PS; Klepser ME; Pashos CL
    Curr Med Res Opin; 2004 Jun; 20(6):779-90. PubMed ID: 15200734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Part 4. Interaction between air pollution and respiratory viruses: time-series study of daily mortality and hospital admissions in Hong Kong.
    Wong CM; Thach TQ; Chau PY; Chan EK; Chung RY; Ou CQ; Yang L; Peiris JS; Thomas GN; Lam TH; Wong TW; Hedley AJ;
    Res Rep Health Eff Inst; 2010 Nov; (154):283-362. PubMed ID: 21446214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of health insurance coverage for oral vancomycin: it's time to tackle the elephant in the room.
    Studemeister A
    Clin Infect Dis; 2011 Mar; 52(5):691-2. PubMed ID: 21292673
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and cost-effectiveness of intracameral vancomycin in reducing postoperative endophthalmitis incidence in Australia.
    Au CP; White AJ; Healey PR
    Clin Exp Ophthalmol; 2016 Dec; 44(9):803-811. PubMed ID: 27311743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections.
    McKinnon PS; Sorensen SV; Liu LZ; Itani KM
    Ann Pharmacother; 2006 Jun; 40(6):1017-23. PubMed ID: 16720705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective drug utilization evaluation of vancomycin usage in paediatric patients.
    Hing WC; Bek SJ; Lin RT; Li SC
    J Clin Pharm Ther; 2004 Aug; 29(4):359-65. PubMed ID: 15271103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.